Science Explorer Interactive view Map
Company · Paris · France

GERCOR (France)

gercor.comROR OpenAlex
Research works
23
▼ 22% vs 2013–17
Citations
772
33.7 per fractional work
Top-10% rate
24.5%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: GERCOR (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.04× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 16.91× its world share, 1 worksImmunology and Micro…Environmental Science: 0.10× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.32× its world share, 0 worksHealth ProfessionsMedicine: 3.60× its world share, 2 worksMedicineDecision Sciences: 7.21× its world share, 0 worksDecision Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.9×. Every wedge is a field page.

Which keywords describe research at GERCOR (France)?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Cetuximab, Precision Medicine, BRAF Mutation, Fluorouracil, KRAS Mutations, Clinical Practice Guidelines and Neoadjuvant Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 29 words, with their numbers
  1. Chemotherapy6▲ 37×12 topics
  2. Cetuximab4▲ 184×2 topics
  3. Precision Medicine3▲ 48×2 topics
  4. BRAF Mutation3▲ 203×2 topics
  5. Fluorouracil3▲ 435×1 topic
  6. KRAS Mutations3▲ 435×1 topic
  7. Clinical Practice Guidelines3▲ 23×5 topics
  8. Neoadjuvant Therapy2▲ 40×3 topics
  9. Tumor Microenvironment2▲ 24×3 topics
  10. Quality of Life2▲ 5.6×4 topics
  11. Adjuvant Chemotherapy2▲ 95×2 topics
  12. Immunotherapy2▲ 11×7 topics
  13. Inflammation1▲ 2.7×11 topics
  14. Molecular Characterization1▲ 34×3 topics
  15. Targeted Therapy1▲ 29×4 topics
  16. Epidemiology1▲ 1.26×10 topics
  17. Preoperative Chemoradiotherapy1▲ 74×2 topics
  18. Aging1▲ 8.9×3 topics
  19. Clinical Trials1▲ 7.5×5 topics
  20. Hepatocellular Carcinoma1▲ 22×2 topics
  21. Immune Checkpoint Blockade1▲ 82×1 topic
  22. Management1▲ 6.2×5 topics
  23. PD-1 and PD-L11▲ 82×1 topic
  24. Survival1▲ 37×2 topics
  25. Survival Analysis1▲ 18×4 topics
  26. Treatment1▲ 3.9×4 topics
  27. Tumor Markers1▲ 69×2 topics
  28. Laparoscopic Surgery1▲ 41×1 topic
  29. Rectal Cancer1▲ 124×1 topic

Which research topics does GERCOR (France) publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research and scientometrics and bibliometrics research.

Cancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCAR-T cell therapy research: 0 fractional worksscientometrics and bibliometrics research: 0 fractional worksPancreatic and Hepatic Oncology Research: 0 fractional worksColorectal Cancer Treatm…0Colorectal Cancer Treatments and Studies: 0 fractional worksAtherosclerosis and Cardiovascular Diseases: 0 fractional worksCholangiocarcinoma and Gallbladder Cancer Studies: 0 fractional worksGastric Cancer Management and Outcomes: 0 fractional worksNutrition and Health in Aging: 0 fractional works
OncologyImmunologyStatistics, Probability and UncertaintySurgery2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
  2. 2 Immunotherapy and Immune Responses Immunology 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 scientometrics and bibliometrics research Statistics, Probability and Uncertainty 0 works
  5. 5 Pancreatic and Hepatic Oncology Research Oncology 0 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 0 works
  7. 7 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
  8. 8 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
  9. 9 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  10. 10 Nutrition and Health in Aging Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.7%not open67.3%

World: 28% of research is openly available.

with international co-authors27.6%domestic only72.4%

World: 19% is written across borders.

How has GERCOR (France)'s research output changed?

Output in 2018–2022 was 22% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Paris

All research institutions in Paris

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.